[ad_1]
Remdesivir, one of the few drugs that works to treat Covid-19, and that Donald Trump also takes, will be sold directly to US hospitals by Gilead, the company that produces it.
For five months, the US Department of Health and Human Services was responsible for assigning this drug to hospitals. This change is due to the fact that the federal institution has not distributed the drug in a transparent way: either it has reached patients, but not necessarily those in need, or some hospitals have not received enough or have simply been left without this treatment.
In the context of this change, Alexandru Rafila, the representative of Romania to the WHO, says that the Ministry of Health must find solutions to acquire this medicine before stocks in Romania are exhausted.
“There are already more than 2,500 patients included in the treatment schemes provided by the European Commission, and once the third installment is delivered, we will probably have to start thinking about doing it ourselves. There will be competition between countries. One is to benefit from a centralized mechanism in which the European Union has another negotiating force and that is why I say that the discussions in the direction of this drug must be addressed in time ”, said Professor Alexandru Rafila.
Patients in Romania still benefit from Remdesivir. Dr. Adrian Marinescu announces that on Sunday 200 doses of Remdesivir were purchased at the Matei Balş Institute in the Capital, in the context in which the majority of Covid-19 patients arrive at this hospital.
“We tried to do some separate steps, precisely because we have a lot of patients with moderate or severe forms and we need Remdesivir. (…) And when it happened in the recent past that it was not Remdesivir, we took action anyway and managed to get it out of other units, ”said Adrian Marinescu, infectious disease physician at the Matei Balş Institute.
[ad_2]
